Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma
2005

PPARγ Expression in Ovarian Cancer

Sample size: 56 publication Evidence: moderate

Author Information

Author(s): G Y Zhang, N Ahmed, C Riley, K Oliva, G Barker, M A Quinn, G E Rice

Primary Institution: Royal Women's Hospital, Melbourne, Australia

Hypothesis

This study evaluates the expression of PPARγ in different pathological grades and subtypes of human epithelial ovarian tumours.

Conclusion

The study found that PPARγ expression is significantly higher in malignant ovarian tumours compared to benign and normal ovaries.

Supporting Evidence

  • PPARγ was not expressed in normal ovaries.
  • 26 out of 28 carcinomas studied were positive for PPARγ expression.
  • An altered staining pattern of PPARγ was observed in high-grade ovarian tumours.

Takeaway

The study shows that a protein called PPARγ is found more in cancerous ovarian tissues than in normal ones, which might help us understand ovarian cancer better.

Methodology

The study used immunohistochemistry and Western blot analyses to evaluate PPARγ expression in ovarian tumour tissues.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602244

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication